Logo for Isofol Medical

Isofol Medical Investor Relations Material

Latest events

Logo for Isofol Medical

Investor Meeting

Isofol Medical
Logo for Isofol Medical

Q1 2024

8 May, 2024
Logo for Isofol Medical

Investor Meeting

19 Mar, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies

Latest reports from Isofol Medical

Access all reports
Segment Data
Access more data
Revenue by
Geography
Asia
Expenses by
Financials
Isofol Medical operates as a clinical stage biotech company that develops and commercializes oncology drugs. Its products include arfolitixorin, which is in phase 3 clinical trial for the treatment of colorectal cancer; pentosan sulfate sodium, which has completed a phase 2 clinical trial for ovarian cancer or recurrent bladder cancer indication; new chemical entities, preclinical NCEs; monoclonal antibodies, which are being investigated for immunotherapy treatment of different types of cancer.